Aprea Therapeutics Inc APRE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:44 PM EDT
6.49quote price arrow up+0.42 (+6.92%)
Volume
8,046
52 week range
2.78 - 8.85
Loading...
  • Open5.92
  • Day High6.49
  • Day Low5.91
  • Prev Close6.07
  • 52 Week High8.85
  • 52 Week High Date03/01/24
  • 52 Week Low2.78
  • 52 Week Low Date07/07/23

Key Stats

  • Market Cap35.204M
  • Shares Out5.42M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.02
  • YTD % Change37.66

KEY STATS

  • Open5.92
  • Day High6.49
  • Day Low5.91
  • Prev Close6.07
  • 52 Week High8.85
  • 52 Week High Date03/01/24
  • 52 Week Low2.78
  • 52 Week Low Date07/07/23
  • Market Cap35.204M
  • Shares Out5.42M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.02
  • YTD % Change37.66

RATIOS/PROFITABILITY

  • EPS (TTM)-3.99
  • P/E (TTM)-1.63
  • Fwd P/E (NTM)-2.06
  • EBITDA (TTM)-15.465M
  • ROE (TTM)-67.08%
  • Revenue (TTM)583,239.973
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,449.55%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aprea Therapeutics Inc

 

Profile

MORE
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing novel synthetic lethality-based cancer therapeutics that target DNA damage response (DDR) pathways. Its synthetic lethality product candidate is ATRN-119, a clinical-stage small molecule inhibitor of ataxia telangiectasia and Rad3-related (ATR), a kinase that plays a critical role in DDR. It is targeting WEE1, a kinase that is a key regulator of multiple phases of the cell...
Richard Peters M.D., Ph.D.
Independent Chairman of the Board
Oren Gilad Ph.D.
President, Chief Executive Officer, Director
John Hamill
Chief Financial Officer, Senior Vice President, Secretary
Address
3805 OLD EASTON ROAD
Doylestown, PA
18902
United States

Top Peers

SYMBOLLASTCHG%CHG
NGNE
Neurogene Inc
51.45+2.19+4.44%
EFTR
eFFECTOR Therapeutics Inc
14.45+1.00+7.43%
BIVI
BioVie Inc
0.53-0.0036-0.6747%
FEMY
Femasys Inc
1.57+0.10+6.80%
ACXP
Acurx Pharmaceuticals Inc
2.36+0.03+1.29%